News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Low CD4 count news

Show

From To
Health monitoring in resource-limited settings
Are CD4 counts still useful in the 'treat all' era?

CD4 cell testing before starting treatment is still essential even in the era of 'treat all' guidelines, two studies from southern Africa presented at the Conference on

Published
08 March 2019
By
Keith Alcorn
Low CD4 count
‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

There are tens of thousands of immunologic non-responders in the U.S., whose low CD4 numbers put them at much higher risk of heart attacks, stroke, cancers, secondary infections such as tuberculosis, and death. And yet, drug companies and researchers aren’t actively pursuing new treatments that would boost their immunity.

Published
08 January 2019
From
STAT
TB transmission and prevention
Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment

The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B

Published
06 June 2018
By
Michael Carter
Treatment outcomes and life expectancy
First-line ART failure common among hospitalised HIV-positive people in sub-Saharan Africa

A large proportion of hospitalised HIV-positive people in sub-Saharan Africa have experienced the failure of first-line antiretroviral therapy (ART), according to a study published in

Published
12 April 2018
By
Michael Carter
Low CD4 count
REALITY study shows which HIV-positive people with very low CD4 cell counts are at highest risk of dying soon after starting treatment

Mortality in people with a low CD4 cell count at the time of HIV diagnosis is associated with a group of risk factors including a

Published
05 April 2018
By
Michael Carter
Opportunistic infections
WHO recommends package of tests, treatment and prevention for 'urgent need' people with HIV with low CD4 counts

A new package of measures to ensure rapid initiation of antiretroviral treatment and diagnosis of opportunistic infections has been recommended by the World Health Organization (WHO) to

Published
23 July 2017
By
Keith Alcorn
Adherence
Screening for cryptococcal meningitis and adherence support reduce mortality among people starting ART in Africa

Screening and treatment for cryptococcal meningitis combined with a short period of adherence support has the potential to significantly reduce mortality rates among people with very low

Published
24 March 2015
By
Michael Carter
Cancer
Low CD4 count important risk factor for oral HPV infection in patients with HIV

A low CD4 count is the single most important risk factor for oral human papillomavirus (HPV) infection in HIV-positive patients, investigators from the United States report in the

Published
23 February 2015
By
Michael Carter
Treatment outcomes and life expectancy
Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France

A large French study has shown that the vast majority of people living with HIV who started treatment since 2000 in a national cohort achieved a CD4

Published
12 November 2014
By
Alain Volny-Anne
Low CD4 count
Regular clinic attendance especially beneficial for people with HIV who have low CD4 counts

People taking HIV treatment who have a low CD4 cell count are especially likely to achieve an undetectable viral if they attend their routine clinic appointments, research published

Published
09 January 2014
By
Michael Carter
← First12Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.